Follow
Duygu Demiröz
Duygu Demiröz
Max Perutz Labs
Verified email at univie.ac.at
Title
Cited by
Cited by
Year
A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription
E Platanitis, D Demiroz, A Schneller, K Fischer, C Capelle, M Hartl, ...
Nature communications 10 (1), 2921, 2019
1712019
The tumor suppressor Hace1 is a critical regulator of TNFR1-mediated cell fate
L Tortola, R Nitsch, MJM Bertrand, M Kogler, Y Redouane, I Kozieradzki, ...
Cell reports 15 (7), 1481-1492, 2016
682016
Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine
A Zaleska, T Eiwegger, Ö Soyer, W Van De Veen, C Rhyner, MB Soyka, ...
Allergy 69 (9), 1162-1170, 2014
592014
Novel NLRP3/cryopyrin mutations and pro-inflammatory cytokine profiles in Behçet’s syndrome patients
Ş Yüksel, E Eren, G Hatemi, AC Sahillioğlu, Y Gültekin, D Demiröz, ...
International immunology 26 (2), 71-81, 2014
432014
Listeria monocytogenes infection rewires host metabolism with regulatory input from type I interferons
D Demiroz, E Platanitis, M Bryant, P Fischer, M Prchal-Murphy, A Lercher, ...
PLoS Pathogens 17 (7), e1009697, 2021
72021
Homeostatic and Interferon-induced gene expression represent different states of promoter-associated transcription factor ISGF3
E Platanitis, D Demiroz, C Capelle, A Schneller, M Hartl, T Gossenreiter, ...
bioRxiv, 377275, 2018
22018
Erratum: Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine (Allergy: European Journal of Allergy and Clinical Immunology (2014 …
A Zaleska, T Eiwegger, W Van De Veen, C Rhyner, MB Soyka, C Bekpen, ...
Allergy: European Journal of Allergy and Clinical Immunology 71 (1), 129, 2016
2016
ORIGINAL RESEARCH PAPERS
Ş Yüksel, E Eren, G Hatemi, AC Sahillioglu, Y Gültekin, D Demiröz, ...
2014
The system can't perform the operation now. Try again later.
Articles 1–8